These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12893059)

  • 1. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
    Laing GD; Renjifo JM; Ruiz F; Harrison RA; Nasidi A; Gutierrez JM; Rowley PD; Warrell DA; Theakston RD
    Toxicon; 2003 Jul; 42(1):35-41. PubMed ID: 12893059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
    Harrison RA; Oluoch GO; Ainsworth S; Alsolaiss J; Bolton F; Arias AS; Gutiérrez JM; Rowley P; Kalya S; Ozwara H; Casewell NR
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005969. PubMed ID: 29045429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
    Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the intrageneric neutralization scope of monospecific, bispecific/monogeneric and polyspecific/monogeneric antisera raised in horses immunized with sub-Saharan African snake venoms.
    Sánchez A; Durán G; Segura Á; Herrera M; Vargas M; Villalta M; Arguedas M; Moscoso E; Umaña D; Gómez A; Gutiérrez JM; León G
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012187. PubMed ID: 38809847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.
    Ainsworth S; Menzies SK; Casewell NR; Harrison RA
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008579. PubMed ID: 32817682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics meets biology: application to the design and preclinical assessment of antivenoms.
    Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
    Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.
    Potet J; Smith J; McIver L
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007551. PubMed ID: 31233536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context.
    Brown NI
    PLoS Negl Trop Dis; 2012; 6(6):e1670. PubMed ID: 22679521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and prospects of snake antivenom supply in sub-Saharan Africa.
    Habib AG; Musa BM; Iliyasu G; Hamza M; Kuznik A; Chippaux JP
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008374. PubMed ID: 32817674
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of a WHO workshop on the standardization and control of antivenoms.
    Theakston RD; Warrell DA; Griffiths E
    Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: Insights from combined antivenomics and neutralization assays.
    Gutiérrez JM; Tsai WC; Pla D; Solano G; Lomonte B; Sanz L; Angulo Y; Calvete JJ
    Toxicon; 2013 Mar; 64():60-9. PubMed ID: 23313380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic biology tackles global antivenom shortage.
    Arnold C
    Nature; 2016 Apr; 532(7599):292. PubMed ID: 27111610
    [No Abstract]   [Full Text] [Related]  

  • 17. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.
    Ratanabanangkoon K; Tan KY; Eursakun S; Tan CH; Simsiriwong P; Pamornsakda T; Wiriyarat W; Klinpayom C; Tan NH
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004565. PubMed ID: 27058956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.